ABS0935 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II CLINICAL TRIAL TO EVALUATE THE PRELIMINARY EFFICACY, SAFETY OF REPEATED ADMINISTRATION OF XELIGEKIMAB (GR1501) INJECTION IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITISDong Xu, Norella Kong, Jing Hu et al.|Annals of the Rheumatic Diseases|2025Cited by 1